Cancer immunotherapy: the indolent B-cell malignancies as a tumor model

• Grant number: 01/04492-8
• Support Opportunities: Scholarships abroad - Research
• Start date: October 01, 2001
• End date: September 30, 2002
• Field of knowledge: Health Sciences - Medicine
• Principal Investigator: Belinda Pinto Simoes
• Grantee: Belinda Pinto Simoes
• Host Investigator: Hans Jochem Kolb
• Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
• Institution abroad: Ludwig Maximilian University of Munich (LMU Munich), Germany
• Associated research grant: 98/14247-6 - Center for Research on Cell-Based Therapy, AP.CEPID

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

BUHMANN, R.; SIMOES, B.; STANGLMAIER, M.; YANG, T.; FALTIN, M.; BUND, D.; LINDHOFER, H.; KOLB, H-J. Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion. BONE MARROW TRANSPLANTATION, v. 43, n. 5, p. 383-397, MAR 2009. (01/04492-8)